Is Pharma back on growth track? Here's why Axis Securities is betting on Lupin, Cipla and Aurobindo Pharma
Axis Securities is betting on Lupin, Cipla and Aurobindo Pharma with up to 19 per cent upside potential.
Source: businesstoday.in
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharma Back. Real-time updates on events, politics, business and more.